Truveta Valuation Estimate
Truveta Valuation as of Last Funding Round
Truveta Company Overview
Truveta is a leading provider of home electronic health record (EHR) data and analytics. Their mission is to empower researchers with fast, compliant, and scientifically rigorous analytics, allowing them to study safety and efficacy, improve patient care, and train medical AI. Trusted by healthcare and life science organizations, Truveta is a collective of over 30 health systems that provide more than 18% of daily clinical care in the US. With access to daily updated data from nearly 100 million patients nationwide, Truveta Studio offers immediate and cost-effective solutions for scientific research.
Truveta Valuation History
Truveta Stock Price
The stock price of Truveta can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Truveta has issued 250 million shares, at the estimated UpMarket valuation of $95.72 million, each share of Truveta stock would be worth $0.38.
Buy Truveta Stock
If you would like to buy shares in Truveta, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Truveta stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Truveta as well.